#BEGIN_DRUGCARD DB07817

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C19H20N6O3S2

# Chemical_IUPAC_Name:
1-{3-[4-(pyridin-2-yl)piperazine-1-sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:26:12 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

# HET_ID:
GAX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C19H20N6O3S2/c26-18(23-19-21-8-13-29-19)22-15-4-3-5-16(14-15)30(27,28)25-11-9-24(10-12-25)17-6-1-2-7-20-17/h1-8,13-14H,9-12H2,(H2,21,22,23,26)

# InChI_Key:
InChIKey=NJPVZSIGDRLLTD-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7823

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
444.531

# Molecular_Weight_Mono:
444.103829916

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.78

# Predicted_LogS:
-3.4

# Predicted_Water_Solubility:
1.70e-01 g/l

# Primary_Accession_No:
DB07817

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
12087505

# PubChem_Substance_ID:
99444288

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O=C(NC1=NC=CS1)NC1=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C1=CC=CC=N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:05 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AP006716

# Drug_Target_1_GenBank_ID_Protein:
68445726

# Drug_Target_1_GeneCard_ID:
pheS

# Drug_Target_1_Gene_Name:
pheS

# Drug_Target_1_Gene_Sequence:
>1356 bp
ATGTCAGAACAAGAAATTTGGAAAAAAGTATTAGAAGTTGCTGAATCAGAAATATCTAAA
TCGACATTTAATACTTTTTTGAAAGATACAGAACTCAAAGAAATTCGTGATAATGTTGCA
ATCATCTTTGTAATTCATGAATTTTACGCAGAATGGTTAAATTCAAACTACAAAGAAGTA
ATCCAAACAATTATGAAAGATGTTATTGGTTATGAAGTTGAACCCAAATTTTTCACTGCT
GAACAATTAGCTGAACTTGATGAGACAAGTCGTAAATCTAACACGCCAAGCGAACCTCAA
CGTCAAATCATTGAATATGGTCATGAAGGCACAGATCAATTCAATACTCACAATACATTT
GATACTTTCGTCATTGGACCTGGCAATAGATTTCCACACGCAGCAAGTCTTGCAGTTGCT
GAAGCACCAGCACAAGCATACAACCCTCTATTTATATATGGTGGCGTTGGTCTTGGTAAG
ACACATCTTATGCATGCGATCGGTCATCATGTTCTTAGCAATCAACCAAATGCTAAAGTA
CTATATACTTCAAGTGAAAAATTCACAAATGACTTCATCAAATCAATTCGTAACAATGAA
CCTGAAGCCTTTAGAGAAAAGTATAGAAACATCGACGTGTTACTGATTGATGACATTCAA
TTTATTCAGAATAAAGAACAAACGCAAGAAGAGTTCTTCCATACATTTAATGAATTACAT
CAAAATAAGAAGCAAATTGTCATTTCAAGTGACCGTCCACCTAAAGAAATTGCAAAATTA
GAAGACCGTTTACGTTCTCGTTTCGAATGGGGATTAATCGTTGATATTACTCCTCCTGAC
TATGAAACACGTATGGCGATTCTTCAGAAAAAAATCGAAGAAGAGAATTTAGAAATTCCT
GCTGAAGCTTTAAATTATATTGCTAATCAAATTCAATCAAACATCCGTGAATTAGAAGGC
GCACTCACACGTTTGCTTGCCTATTCTAAACTTCAAGGCAGACCTATTACGACTGAATTA
GCGGCAGAAGCGCTCAAAGATATTATTCAAGTTCCTAAATCTAAAAAAATTACAATCCAA
GATATTCAAAAAGTCGTTGGACACTACTACAACGTTCGCATCGAAGATTTCAGCGCAAAA
AAACGTACAAAATCAATTGCTTATCCACGTCAAATTGCGATGTATTTATCAAGAGAACTT
ACCGATTTTTCATTACCTAAGATTGGTGAAGAATTCGGTGGTCGAGATCATACGACAGTG
ATTCATGCGCACGAAAAGATTGCTAAAGATATTAAAGCCGATACAATTTTTAAACAAGAA
GTTGAAGATTTGGAAAAAGAAATTCGCAATCAATAA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
16237012	Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K: Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol. 2005 Nov;187(21):7292-308.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6602

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
40137.3

# Drug_Target_1_Name:
Phenylalanyl-tRNA synthetase alpha chain

# Drug_Target_1_Number_of_Residues:
352

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01409	tRNA-synt_2d
PF02912	Phe_tRNA-synt_N

# Drug_Target_1_Protein_Sequence:
>Phenylalanyl-tRNA synthetase alpha chain
MTQNDSMAELKQQALVDINEAQNERELQDVKVKYLGKKGSVSGLMKNMKDLPNEEKPAYG
QKVNELRQTIQKELDEKQELLKNEKLNQQLAEETIDVTLPSRQISIGSKHPLTRTVEEIE
DLFLGLGYEIVDGYEVEQDYYNFEALNLPKSHPARDMQDSFYITDEILMRTHTSPVQART
MEKRNGQGPVKIICPGKVYRRDSDDATHSHQFTQIEGLVVDKNIKMSDLKGTLELVAKKL
FGADREIRLRPSYFPFTEPSVEVDVSCFKCKGKGCNVCKHTGWIEILGAGMVHPNVLEMA
GFDSNEYSGFAFGMGPDRIAMLKYGIEDIRYFYTNDVRFLEQFKAVEDRGEA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + L-phenylalanine + tRNA(Phe) = AMP + diphosphate + L-phenylalanyl-tRNA(Phe)

# Drug_Target_1_SwissProt_ID:
Q4L5E3

# Drug_Target_1_SwissProt_Name:
SYFA_STAHJ

# Drug_Target_1_Synonyms:
PheRS
Phenylalanine--tRNA ligase alpha chain

# Drug_Target_1_Theoretical_pI:
5.03

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AP006716

# Drug_Target_2_GenBank_ID_Protein:
68445726

# Drug_Target_2_GeneCard_ID:
pheT

# Drug_Target_2_Gene_Name:
pheT

# Drug_Target_2_Gene_Sequence:
>1356 bp
ATGTCAGAACAAGAAATTTGGAAAAAAGTATTAGAAGTTGCTGAATCAGAAATATCTAAA
TCGACATTTAATACTTTTTTGAAAGATACAGAACTCAAAGAAATTCGTGATAATGTTGCA
ATCATCTTTGTAATTCATGAATTTTACGCAGAATGGTTAAATTCAAACTACAAAGAAGTA
ATCCAAACAATTATGAAAGATGTTATTGGTTATGAAGTTGAACCCAAATTTTTCACTGCT
GAACAATTAGCTGAACTTGATGAGACAAGTCGTAAATCTAACACGCCAAGCGAACCTCAA
CGTCAAATCATTGAATATGGTCATGAAGGCACAGATCAATTCAATACTCACAATACATTT
GATACTTTCGTCATTGGACCTGGCAATAGATTTCCACACGCAGCAAGTCTTGCAGTTGCT
GAAGCACCAGCACAAGCATACAACCCTCTATTTATATATGGTGGCGTTGGTCTTGGTAAG
ACACATCTTATGCATGCGATCGGTCATCATGTTCTTAGCAATCAACCAAATGCTAAAGTA
CTATATACTTCAAGTGAAAAATTCACAAATGACTTCATCAAATCAATTCGTAACAATGAA
CCTGAAGCCTTTAGAGAAAAGTATAGAAACATCGACGTGTTACTGATTGATGACATTCAA
TTTATTCAGAATAAAGAACAAACGCAAGAAGAGTTCTTCCATACATTTAATGAATTACAT
CAAAATAAGAAGCAAATTGTCATTTCAAGTGACCGTCCACCTAAAGAAATTGCAAAATTA
GAAGACCGTTTACGTTCTCGTTTCGAATGGGGATTAATCGTTGATATTACTCCTCCTGAC
TATGAAACACGTATGGCGATTCTTCAGAAAAAAATCGAAGAAGAGAATTTAGAAATTCCT
GCTGAAGCTTTAAATTATATTGCTAATCAAATTCAATCAAACATCCGTGAATTAGAAGGC
GCACTCACACGTTTGCTTGCCTATTCTAAACTTCAAGGCAGACCTATTACGACTGAATTA
GCGGCAGAAGCGCTCAAAGATATTATTCAAGTTCCTAAATCTAAAAAAATTACAATCCAA
GATATTCAAAAAGTCGTTGGACACTACTACAACGTTCGCATCGAAGATTTCAGCGCAAAA
AAACGTACAAAATCAATTGCTTATCCACGTCAAATTGCGATGTATTTATCAAGAGAACTT
ACCGATTTTTCATTACCTAAGATTGGTGAAGAATTCGGTGGTCGAGATCATACGACAGTG
ATTCATGCGCACGAAAAGATTGCTAAAGATATTAAAGCCGATACAATTTTTAAACAAGAA
GTTGAAGATTTGGAAAAAGAAATTCGCAATCAATAA

# Drug_Target_2_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_2_General_References:
16237012	Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K: Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol. 2005 Nov;187(21):7292-308.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6603

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
88875.6

# Drug_Target_2_Name:
Phenylalanyl-tRNA synthetase beta chain

# Drug_Target_2_Number_of_Residues:
800

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01588	tRNA_bind
PF03147	FDX-ACB
PF03483	B3_4
PF03484	B5

# Drug_Target_2_Protein_Sequence:
>Phenylalanyl-tRNA synthetase beta chain
MLISNEWLKDYVDAGVKVEDLAERITRTGIEVDDMIDYSKDIKNLVVGYIQSKEKHPDAD
KLNICQVDIGEEEPVQIVCGAPNVDAGQHVIVAKVGGRLPGGIKIKRAKLRGERSEGMIC
SLQEIGISSNVVPKAYENGIFVFQTEVEPGTDALTALYLNDQVMEFDLTPNRADALSMVG
TAYEVAALYQTEMTKPETQSNETSESATNELSVTIDNPEKVPYYSARVVKNVSIEPSPIW
VQARLIKAGIRPINNVVDISNYVLLEYGQPLHMFDQDHIGSKEIVVRQAKDEETMTTLDN
NERKLVDTDIVISNGQEPIALAGVMGGDFSEVTEQTTNVVIEGAIFDPVSIRHTSRRLNL
RSEASSRFEKGIATEFVDEAVDRACYLLQELASGEVLQDRVSSGDLGSFVTPIDITAEKV
NKTIGFNLSNDEIQSIFRQLGFETTLKGETLTVNVPSRRKDITIKEDLIEEVARIYGYDE
IPSSLPVFGEVTSGELTDRQHKTRTLKETLEGAGLNQAITYSLVSKDHAKDFALQERPTI
SLLMPMSEAHATLRQSLLPHLIEATAYNVARKNKDVRLYEIGRVFFGNGEGELPDEVEYL
SGILTGEYVVNAWQGKKEEIDFFIAKGVVDRVAEKLNLEFSYKAGKIEGLHPGRTAIVSL
EGQDIGFIGELHPQVAADNDLKRTYVFELNYDAMMQVAVGYINYEQIPKFPGVTRDIALE
VNHDVPSSELKQIIHNNGEDILQSTLVFDVYEGEHLEKGKKSVAIRLNYLDTEDTLTDER
VSKIHDKILEALQAQGATIR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + L-phenylalanine + tRNA(Phe) = AMP + diphosphate + L-phenylalanyl-tRNA(Phe)

# Drug_Target_2_SwissProt_ID:
Q4L5E4

# Drug_Target_2_SwissProt_Name:
SYFB_STAHJ

# Drug_Target_2_Synonyms:
PheRS
Phenylalanine--tRNA ligase beta chain

# Drug_Target_2_Theoretical_pI:
4.49

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB07817
